{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:41:43Z","timestamp":1790743303626,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.transproceed.2010.04.052","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T10:11:54Z","timestamp":1284372714000},"page":"2503-2508","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of Cinacalcet HCl Treatment After Kidney Transplantation"],"prefix":"10.1016","volume":"42","author":[{"given":"J.B.","family":"Copley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Pankewycz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Katznelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.04.052_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2010.04.052_bib2","first-page":"7","article-title":"Report on management of renal failure in europe, XXII, 1991","volume":"7","author":"Raine","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib3","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.transproceed.2007.10.001","article-title":"Renal osteodystrophy after successful renal transplantation: A histomorphometric analysis in 57 patients","volume":"39","author":"Lehmann","year":"2007","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.transproceed.2010.04.052_bib4","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/j.1600-6143.2007.01950.x","article-title":"Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"7","author":"Borchhardt","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1681\/ASN.V132551","article-title":"Calcium metabolism and skeletal problems after transplantation","volume":"13","author":"Torres","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.04.052_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000110875","article-title":"Abnormal bone and mineral metabolism in kidney transplant patients\u2013a review","volume":"28","author":"Sprague","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2010.04.052_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1359\/jbmr.1999.14.3.456","article-title":"Increased risk of fracture in patients receiving solid organ transplants","volume":"14","author":"Ramsey-Goldman","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.transproceed.2010.04.052_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.V94677","article-title":"Analysis of fracture prevalence in kidney-pancreas allograft recipients","volume":"9","author":"Chiu","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.04.052_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","article-title":"Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure","volume":"21","author":"Egbuna","year":"2007","journal-title":"Clinical Transplantation"},{"key":"10.1016\/j.transproceed.2010.04.052_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00553-5","article-title":"K\/doqi clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2010.04.052_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ki.2008.549","article-title":"Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients","volume":"75","author":"Courbebaisse","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.04.052_bib12","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"Engl J Med"},{"key":"10.1016\/j.transproceed.2010.04.052_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2010.04.052_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/TP.0b013e31817c13e1","article-title":"Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism","volume":"86","author":"Bergua","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.04.052_bib15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e318186b7fb","article-title":"Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"86","author":"Borchhardt","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.04.052_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ndt\/gfl560","article-title":"Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients","volume":"22","author":"Serra","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib17","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1523-1755.1998.00142.x","article-title":"Persistent secondary hyperparathyroidism after renal transplantation","volume":"54","author":"Messa","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.04.052_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2010.04.052_bib19","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephrol"},{"key":"10.1016\/j.transproceed.2010.04.052_bib20","first-page":"211","article-title":"Neurobehavioral symptoms in mild primary hyperparathyroidism: Related to hypercalcemia but not improved by parathyroidectomy","volume":"35","author":"Brown","year":"1987","journal-title":"Henry Ford Hosp Med J"},{"key":"10.1016\/j.transproceed.2010.04.052_bib21","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2010.04.052_bib22","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2010.04.052_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.04.052_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","article-title":"High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation","volume":"11","author":"Monier-Faugere","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.04.052_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI114840","article-title":"Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin d in the rat","volume":"86","author":"Neveh-Many","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transproceed.2010.04.052_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(97)10535-9","article-title":"Magnesium and phosphorus","volume":"352","author":"Weisinger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2010.04.052_bib27","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/ndt\/13.10.2605","article-title":"Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients","volume":"13","author":"Caravaca","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with ckd not receiving dialysis","volume":"45","author":"Charytan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2010.04.052_bib29","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2010.04.052_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.mnh.0000203187.49890.cc","article-title":"Post-renal transplantation hypophosphatemia: A review and novel insights","volume":"15","author":"Ghanekar","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.transproceed.2010.04.052_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0009-9236(03)00168-1","article-title":"Genetic polymorphisms of the cyp3a4, cyp3a5, and mdr-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus","volume":"74","author":"Hesselink","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2010.04.052_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00003088-200140080-00002","article-title":"Clinical pharmacokinetics of sirolimus","volume":"40","author":"Mahalati","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2010.04.052_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00126839-200809050-00004","article-title":"Cinacalcet does not effect the activity of cytochrome p450 3a enzymes, a metabolic pathway for common immunosuppressive agents: a randomized, open-label, crossover, single-centre study in healthy volunteers","volume":"9","author":"Padhi","year":"2008","journal-title":"Drugs in R&D"},{"key":"10.1016\/j.transproceed.2010.04.052_bib34","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfm632","article-title":"Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycohenolate in renal transplant recipients","volume":"23","author":"Fal\u010dk","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jcem-52-1-111","article-title":"Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man","volume":"52","author":"Hahn","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2010.04.052_bib36","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.TP.0000137937.44703.42","article-title":"Calcium and calcitriol prophylaxis attenuates posttransplant bone loss","volume":"78","author":"Josephson","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.04.052_bib37","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl 3","key":"10.1016\/j.transproceed.2010.04.052_bib38","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1177\/089686080102103S45","article-title":"Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues","volume":"21","author":"Rodd","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.transproceed.2010.04.052_bib39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfl583","article-title":"Decreased renal transplant function after parathyroidectomy","volume":"22","author":"Schwarz","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.tp.0000253429.33198.2f","article-title":"Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation","volume":"83","author":"El-Amm","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.04.052_bib41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","article-title":"The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism","volume":"20","author":"Kruse","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib42","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","article-title":"Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism","volume":"20","author":"Serra","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.00500705","article-title":"Improvement in hypercalcemia with cinacalcet after kidney transplantation","volume":"1","author":"Srinivas","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.04.052_bib44","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1600-6143.2006.01475.x","article-title":"Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet","volume":"6","author":"Leca","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib45","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/ndt\/gfn345","article-title":"Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose","volume":"23","author":"Kamar","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.04.052_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.tp.0000232452.80018.ad","article-title":"Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism","volume":"82","author":"Szwarc","year":"2006","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510009279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510009279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T18:42:13Z","timestamp":1636483333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510009279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0041134510009279"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.04.052","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}